United Kingdom · Question · Written question
UIN 69062
Casirivimab/imdevimab
Original
Introduced
3 November 2021
Last action
6 December 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
6 December 2021
Summary
To ask the Secretary of State for Health and Social Care, how many people have been treated with Ronapreve for covid-19 (a) in each week and (b) in each clinical commissioning group area since that treatment became available; and how many of those recipie
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 November 2021
Written question
To ask the Secretary of State for Health and Social Care, how many people have been treated with Ronapreve for covid-19 (a) in each week and (b) in each clinical commissioning group area since that treatment became available; and how many of those recipie
Source: Commons
6 December 2021
Answer
An interim clinical policy for Ronapreve (casirivimab and imdevimab) was published on 17 September 2021 and updated on 4 November. Since September 2021, over 1,200 patients in England have received this treatment.NHS England and NHS Improvement collect in...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-03/69062
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1365992
- uk · wq-1365992 · source updated 6 December 2021